Promesa y Esperanza® Broadcast Rallies Hispanic Media, Artists, and Fans to Support St. Jude Children’s Research Hospital

Nationwide Event Raises $5.2 Million for St. Jude families MEMPHIS, Tenn.–(BUSINESS WIRE)–The St. Jude Promesa y Esperanza® (Promise and Hope) broadcast earlier this month brought together Hispanic media leaders, Latin music artists, and Spanish-speaking audiences to support research and treatment at St. Jude Children’s Research Hospital®. The event, part of the Music Gives to St. … [Read more…]

HCA Healthcare, Inc. 4th Quarter 2025 Earnings Conference Call

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What:   HCA Healthcare, Inc. 4Q 2025 Earnings Call When:   Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How:   Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to … [Read more…]

Eurofins Scientific SE: Director/PDMR Shareholding

LUXEMBOURG–(BUSINESS WIRE)–Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS … [Read more…]

3D Printing for Medical Devices Training Course (Online Event: June 17, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Future of Manufacturing: 3D Printing for Medical Devices Training Course (June 17, 2026)” training has been added to ResearchAndMarkets.com’s offering. The global market for medical devices and equipment is estimated to have been worth $739.6 billion in 2023. It is a thriving industry which is expected to grow at compound annual growth … [Read more…]

2 Day Virtual Cyber Security for Medical Devices Training Course: Regulatory Focus and Best Practices for Embedding State-of-the-Art Security Into Products and Processes (Mar 19th – Mar 20th, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cyber Security for Medical Devices Training Course (Mar 19th – Mar 20th, 2026)” training has been added to ResearchAndMarkets.com’s offering. The impact of Cyber Security incidents on society is high, and in critical infrastructures such as healthcare it impacts the ability for hospitals to provide care. Cybersecurity for medical devices is not just … [Read more…]

2026 Future of Fitness Report: Coherent Solutions Draws on Years of Fitness Software Engineering to Show How Digital Ecosystems Will Set the Pace for the Middle East’s Fitness Boom

MINNEAPOLIS–(BUSINESS WIRE)–Coherent Solutions has released its 2026 Future of Fitness report, capturing years of domain knowledge from helping emerging and global fitness brands drive digital transformation, innovate, and improve member engagement. “The Future of Fitness: Winning with Digital Value Creation” takes lessons from real projects and fitness enthusiasts. The report comes as the Middle East … [Read more…]

Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 9:45 a.m. Pacific Time. Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. A replay … [Read more…]

Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that following evaluation of interim data from the RAMP 203 clinical trial in advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC) it will discontinue the trial to focus resources on clinical development of VS-7375, … [Read more…]

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th – Mar 26th, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th – Mar 26th, 2026)” training has been added to ResearchAndMarkets.com’s offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a … [Read more…]

ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of “100 Most Influential People in Oncology in 2025”

CULVER CITY, Calif.–(BUSINESS WIRE)–ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that OncoDaily has recognized Dr. Patrick Soon-Shiong as being one of “The 100 Most Influential People in Oncology in 2025.” Soon-Shiong is the company’s Founder, Executive Chairman and Global Chief Scientific and Medical Officer, and is a global thought leader in advancing … [Read more…]